Kozak & Associates’s Livent Corporation LTHM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-230
Closed -$3.92K 420
2023
Q3
$3.92K Hold
230
﹤0.01% 302
2023
Q2
$6.49K Hold
230
﹤0.01% 259
2023
Q1
$5K Hold
230
﹤0.01% 269
2022
Q4
$5K Hold
230
﹤0.01% 274
2022
Q3
$7K Hold
230
﹤0.01% 256
2022
Q2
$5K Hold
230
﹤0.01% 295
2022
Q1
$5K Hold
230
﹤0.01% 317
2021
Q4
$5K Hold
230
﹤0.01% 317
2021
Q3
$7K Buy
+230
New +$5.16K ﹤0.01% 266

Other funds holding LTHM

Kozak & Associates's LTHM Position: Q4 2023 in Review

Kozak & Associates sold out of Livent Corporation (LTHM) in Q4 2023, closing a stake of 230 shares — an estimated $3.92K sold.

Kozak & Associates first reported a position in LTHM in Q3 2021 and held it in 9 quarters. The position peaked at $7K in Q3 2022. 382 funds tracked by Wall St. Rank hold LTHM as of Q4 2023.

  • Kozak & Associates reported no remaining Livent Corporation position as of Q4 2023 after selling out during the quarter.
  • Kozak & Associates sold 230 Livent Corporation shares in Q4 2023, an estimated $3.92K.
  • Kozak & Associates first reported a position in Livent Corporation in Q3 2021 and held it in 9 quarters.
  • Kozak & Associates's Livent Corporation position peaked at $7K in Q3 2022.
  • 382 funds tracked by Wall St. Rank held Livent Corporation as of Q4 2023.

Based on Kozak & Associates's 13F filing for Q4 2023, filed 17 Jan 2024.